Year: 2020

TEMPE, Ariz., Nov. 17, 2020 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (the “Company” or “Wrap”) (Nasdaq: WRTC), an innovator of modern policing solutions, announced today 4 key additions to the Company’s inside and outside sales teams, including Directors of Western Regional Sales and Eastern Regional Sales.“We are excited to be introducing additional talent to our sales department,” said Tom Smith, President and Interim CEO of Wrap Technologies. “We continue to see a strong pipeline of inbound requests for BolaWrap demonstrations, training and quotes, and many agencies who have previously seen demos or have been trained on the BolaWrap are now beginning to outfit their officers with our device.”“With 13 distributors across the US covering 49 states and a majority of domestic sales coming through our distribution network, it is...

Vancouver, B.C., Nov. 17, 2020 (GLOBE NEWSWIRE) — Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) is focused on the exploration and development of flake graphite in Quebec for the new green economy.  Lomiko is pleased to announce the Board of Directors has formed a Technical, Safety, and Sustainability Committee (“LTSSC”), reporting to the Board of Directors.  At the time of formation, the LTSCC is comprised of A. Paul Gill, CEO, and two Independent Directors, Gabriel Erdelyi and Julius Galik. LTSSC Committee Responsibilities The LTSSC will oversee the assessment of the La Loutre Flake Graphite Property, and liaise with service providers, technical staff and stakeholders to put forward a series of crucial technical documents including, but not limited to, a Scope of Work (SOW), Graphite Characterization and Metallurgy,...

* Dr. Schwartz Served as ArQule’s Chief Medical Officer and Head of Research and Development Prior to the $2.7 billion Acquisition of ArQule by Merck in February 2020 *Nes Ziona, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today announced that Brian Schwartz, MD, who served for twelve years as Chief Medical Officer of ArQule, Inc. and led ArQule’s research and development programs through its $2.7 billion acquisition by Merck earlier this year, joined the Enlivex Board of Directors on November, 15, 2020.Dr. Schwartz commented, “I am excited to be joining the Board of Directors of Enlivex. After carefully reviewing the scientific basis and data for AllocetraTM, which is currently in clinical development for sepsis and COVID-19, and in preclinical...

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — On October 20, 2020, Constellation announced that it had resolved to pay a special dividend of Topicus.com shares, conditional upon receipt by Constellation of such spin-out shares by November 17th. That condition will not be satisfied on or prior to November 17, 2020, and therefore the previously declared conditional dividend will not be paid. Constellation will continue to work toward a public listing of the shares of Topicus.com, and expects that the Topicus.com shares will be distributed to Constellation’s shareholders at a later date. The new record date and payment date for such special dividend will be determined and announced at the appropriate time.Forward Looking StatementsCertain statements herein may be “forward looking” statements that involve known and unknown risks,...

ROSELAND, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter and nine months ending September 30, 2020.Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, commented, “This quarter, our dental business improved considerably as dental offices began to reopen across the country and around the world. Specifically, our dental sales increased more than seven-fold versus the second quarter of 2020. Importantly, our marketing initiatives and ‘back to work’ promotions have been well received, as we are working hard to address the needs of both dentists and their patients during the pandemic.”“With...